# Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2

> **NCT00000327** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Heroin Dependence
- Opioid-Related Disorders

## Interventions

- **DRUG:** Heroin Dependence

## Key facts

- **NCT ID:** NCT00000327
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 1997-06
- **Primary completion:** 1997-08
- **Final completion:** 1997-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000327, "Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*